Green synthesis of Pluronic stabilized reduced graphene oxide: Chemical and biological characterization
Source abstract
Abstract
The wonder material graphene has numerous potential applications in nanoelectronics, biomedicine, storage devices, etc. Synthesis of graphene is highly challenging due to the toxic chemicals used and its low yield. In the present study, a facile green route for synthesis of reduced graphene oxide (rGO) was carried out using ascorbic acid as reducing agent. rGO was stabilized using Pluronic P123 polymer to give Pluronic stabilized reduced graphene oxide (rGO-P) and gave superior yield (15 mg graphene oxide yielded ˜13 mg rGO-P). Despite the potential neuroscience applications of graphene, the impending toxicological outcome upon interaction with neurons is not well understood. Here, differentiated PC-12 neuron-like cells exposed to rGO-P showed a dose-dependent cytotoxicity. Membrane disruption and cytoskeletal integrity remained uncompromised after 24 h exposure. Oxidative stress in PC-12 was evident due to an increase in ROS generation in dose and time-dependent manner. In vivo acute toxicity was assessed in mice administered with 10 mg/kg body weight of rGO-P. There were no evident changes in behaviour, motor function or other morphological changes. In conclusion, rGO-P was successfully synthesized and provided superior yield. Even though in vitro toxicity testing showed dose-dependent toxicity, in vivo toxic effect was not apparent.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Carbon and Quantum Dots Applications · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Honeycomb carbon: a review of graphene10.1021/cr900070d ↗
2. Synthesis of graphene and its applications: a review10.1080/10408430903505036 ↗
3. Graphene‐based nanomaterials : synthesis, properties, and optical and optoelectronic applications10.1002/adfm.201202460 ↗
4. Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges10.2217/nnm.15.68 ↗
5. Role of graphene nano-composites in cancer therapy: theranostic applications, metabolic fate and toxicity issues10.2174/1389200215666141125120633 ↗
6. Advancement in multifunctional nanoparticles for the effective treatment of cancer10.1517/17425247.2012.668522 ↗
7. Graphene‐based nanomaterials: synthesis, properties, and optical and optoelectronic applications10.1002/adfm.201202460 ↗
8. The reduction of graphene oxide10.1016/j.carbon.2011.11.010 ↗
9. Reduction of graphene oxide via L-ascorbic acid10.1039/B917705A ↗
10. Progress of reduction of graphene oxide by ascorbic acid10.1016/j.apsusc.2018.03.243 ↗
11. Biocompatible reduced graphene oxide prepared by using dextran as a multifunctional reducing agent10.1039/c0cc05005a ↗
12. Aqueous dispersion of graphene sheets stabilized by pluronic copolymers: formation of supramolecular hydrogel10.1021/jp9035887 ↗
13. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy10.1021/ja2010175 ↗
14. Enhanced stability of reduced graphene oxide colloid using cross-linking polymers10.1021/jp500205n ↗
15. Functionalization of graphene: covalent and non-covalent approaches, derivatives and applications10.1021/cr3000412 ↗
16. Aqueous dispersion of graphene sheets stabilized by pluronic copolymers: formation of supramolecular hydrogel10.1021/jp9035887 ↗
17. Safety assessment of graphene-based materials: focus on human health and the environment10.1021/acsnano.8b04758 ↗
18. Interfacing graphene-based materials with neural cells10.3389/fnsys.2018.00012 ↗
19. Graphenes & their applications in healthcare systems
20. Graphene oxide nanosheets reshape synaptic function in cultured brain networks10.1021/acsnano.6b00130 ↗
21. Graphene oxide nanosheets disrupt lipid composition, Ca2+ homeostasis, and synaptic transmission in primary cortical neurons10.1021/acsnano.6b03438 ↗
22. Graphene oxide upregulates the homeostatic functions of primary astrocytes and modulates astrocyte-to-neuron communication10.1021/acs.nanolett.8b02487 ↗
23. Reduced graphene oxide induces transient blood–brain barrier opening: an in vivo study10.1186/s12951-015-0143-z ↗
24. Preparation of graphitic oxide10.1021/ja01539a017 ↗
25. Aqueous dispersion of graphene sheets stabilized by pluronic copolymers: formation of supramolecular hydrogel10.1021/jp9035887 ↗
26. Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo10.1021/la302446h ↗
27. Protein measurement with the folin phenol reagent10.1016/S0021-9258(19)52451-6 ↗
28. Cytotoxic potential of silver nanoparticles10.3349/ymj.2014.55.2.283 ↗
29. Noncovalent functionalization of graphene with end-functional polymers10.1039/b919074k ↗
30. Fabrication and characteristics of reduced graphene oxide produced with different green reductants10.1371/journal.pone.0144842 ↗
31. Hydrothermal synthesis of mesostructured ZnO micropyramids with enhanced photocatalytic performance10.1016/j.spmi.2013.08.007 ↗
32. Synthesis, dispersion, and cytocompatibility of graphene oxide and reduced graphene oxide10.1016/j.colsurfb.2011.08.026 ↗
33. Raman spectra of graphite oxide and functionalized graphene sheets10.1021/nl071822y ↗
34. Noncovalent functionalization of graphene with end-functional polymers10.1039/b919074k ↗
35. Biological recognition of graphene nanoflakes10.1038/s41467-018-04009-x ↗
36. Reduction of graphene oxide via L-ascorbic acid10.1039/B917705A ↗
37. Graphene oxide versus reduced graphene oxide as saturable absorbers for Er-doped passively mode-locked fiber laser10.1364/OE.20.019463 ↗
38. Studies of reduced graphene oxide and graphite oxide in the aspect of their possible application in gas sensors
39. Effective noncovalent functionalization of poly (ethylene glycol) to reduced graphene oxide nanosheets through γ-radiolysis for enhanced lubrication10.1021/acs.jpcc.5b08762 ↗
40. Graphene Oxide and pluronic copolymer aggregates–possible route to modulate the adsorption of fluorophores and imaging of live cells10.1021/acs.jpcc.5b05251 ↗
41. The role of basic residues in the adsorption of blood proteins onto the graphene surface10.1038/srep10873 ↗
42. Surface functionalization of nanoparticles with polyethylene glycol: effects on protein adsorption and cellular uptake10.1021/acsnano.5b01326 ↗
43. Graphene: a versatile nanoplatform for biomedical applications10.1039/c2nr31040f ↗
44. Graphene in regenerative medicine: focus on stem cells and neuronal differentiation10.1016/j.tibtech.2016.01.006 ↗
45. Graphene oxide nanosheets disrupt lipid composition, Ca2+ homeostasis, and synaptic transmission in primary cortical neurons10.1021/acsnano.6b03438 ↗
46. Nano-biointeractions of PEGylated and bare reduced graphene oxide on lung alveolar epithelial cells: A comparative in vitro study10.1016/j.colsurfb.2015.12.030 ↗
47. A novel biomolecule-mediated reduction of graphene oxide: a multifunctional anti-cancer agent10.3390/molecules21030375 ↗
48. Toxicity of graphene and graphene oxide nanowalls against bacteria10.1021/nn101390x ↗
49. Green synthesis of graphene and its cytotoxic effects in human breast cancer cells10.2147/IJN.S42047 ↗
50. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways10.1016/j.biomaterials.2011.09.091 ↗
51. Graphene oxide upregulates the homeostatic functions of primary astrocytes and modulates astrocyte-to-neuron communication10.1021/acs.nanolett.8b02487 ↗
52. Toxic potential of materials at the nanolevel10.1126/science.1114397 ↗
53. Antioxidant chemistry of graphene-based materials and its role in oxidation protection technology10.1039/C4NR03275F ↗
54. Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations10.1016/j.biomaterials.2014.04.066 ↗
55. Reduced graphene oxide: nanotoxicological profile in rats10.1186/s12951-016-0206-9 ↗